Effects of the malononitrilamide FK778 on immune functions in vitro in whole blood from non-human primates and healthy human volunteers

被引:20
作者
Bîrsan, T
Dambrin, C
Klupp, J
Stalder, M
Fitzsimmons, WE
Morris, RE
机构
[1] Stanford Univ, Dept Cardiothorac Surg, Sch Med, Stanford, CA 94305 USA
[2] Fujisawa Healthcare Inc, Deerfield, IL 60015 USA
基金
奥地利科学基金会;
关键词
malononitrilamides; leflunomide; FACS; lymphocytes; non-human primates;
D O I
10.1016/S0966-3274(02)00155-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: FK778, a malononitrilamide analog of leflunomide, is currently being investigated for use in clinical transplantation. Methods: Whole blood from cynomolgus monkeys (n=4) and healthy human volunteers (n=4) was incubated with different concentrations of FK778 and stimulated with mitogens in culture medium. Lymphocyte proliferation was assessed by tritium-labeled thymidine incorporation and by flow-cytometric analysis of expression of proliferating cell nuclear antigen on cells in S/G(2)M phase. Flow cytometry was also used to assess expression of T and B lymphocyte activation surface antigens and production of intracellular cytokines by T cells. Results: Not only lymphocyte proliferation, but also expression of various T cell surface antigens (CD25, CD11a, CD95, CD154) was suppressed by FK778. Fifty percent effective concentration values for the different immune functions were lower in human blood than in blood from cynomolgus monkeys. Conclusions: FK778 inhibits multiple immune functions. Their flow cytometric evaluation can be used to assess the effects of the drug in vivo. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 9 条
[1]   Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro [J].
Barten, MJ ;
Gummert, JF ;
van Gelder, T ;
Shorthouse, R ;
Morris, RE .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 253 (1-2) :95-112
[2]   In vivo activity of leflunomide - Pharmacokinetic analyses and mechanism of immunosuppression [J].
Chong, ASF ;
Huang, W ;
Liu, W ;
Luo, JL ;
Shen, JK ;
Xu, W ;
Ma, LL ;
Blinder, L ;
Xiao, F ;
Xu, XL ;
Clardy, C ;
Foster, P ;
Williams, JA .
TRANSPLANTATION, 1999, 68 (01) :100-109
[3]   Comparative effects of malononitriloamide analogs of leflunomide on whole blood lymphocyte stimulation in humans, rhesus macaques, cats, dogs, and rats [J].
Gregory, CR ;
Silva, HT ;
Patz, JD ;
Morris, RE .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) :1047-1048
[4]   Pharmacodynamics of mycophenolic acid in heart allograft recipients: Correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology [J].
Gummert, JF ;
Barten, MJ ;
van Gelder, T ;
Billingham, ME ;
Morris, RE .
TRANSPLANTATION, 2000, 70 (07) :1038-1049
[5]   Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases [J].
Herrmann, ML ;
Schleyerbach, R ;
Kirschbaum, BJ .
IMMUNOPHARMACOLOGY, 2000, 47 (2-3) :273-289
[6]   Leflunomide inhibits pyrimidine de Novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans [J].
Rückemann, K ;
Fairbanks, LD ;
Carrey, EA ;
Hawrylowicz, CM ;
Richards, DF ;
Kirschbaum, B ;
Simmonds, HA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (34) :21682-21691
[7]   Regulation of B cell function by the immunosuppressive agent leflunomide [J].
Siemasko, KF ;
Chong, ASF ;
Williams, JW ;
Bremer, EG ;
Finnegan, A .
TRANSPLANTATION, 1996, 61 (04) :635-642
[8]   Leflunomide and malononitrilamides [J].
Silva, HT ;
Morris, RE .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 313 (05) :289-301
[9]   Flow cytometric analysis of the molecular mechanisms of immunosuppressive action of the active metabolite of leflunomide and its malononitrilamide analogues in a novel whole blood assay [J].
Slauson, SD ;
Silva, HT ;
Sherwood, SW ;
Morris, RE .
IMMUNOLOGY LETTERS, 1999, 67 (03) :179-183